Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Burden and epidemiology of status epilepticus in infants, children, and adolescents: A population‐based study on German health insurance data
Susanne Schubert‐Bast, Johann Philipp Zöllner, Sonja Ansorge, et al.
Epilepsia (2019) Vol. 60, Iss. 5, pp. 911-920
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Management of Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus
Eugen Trinka, Markus Leitinger
CONTINUUM Lifelong Learning in Neurology (2022) Vol. 28, Iss. 2, pp. 559-602
Closed Access | Times Cited: 75
Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability
Ricardo Kienitz, Lara Kay, Isabelle Beuchat, et al.
CNS Drugs (2022) Vol. 36, Iss. 9, pp. 951-975
Open Access | Times Cited: 73
Why won’t it stop? The dynamics of benzodiazepine resistance in status epilepticus
Richard J. Burman, Richard Rosch, Jo M. Wilmshurst, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 7, pp. 428-441
Closed Access | Times Cited: 63
Therapeutic advances in Dravet syndrome: a targeted literature review
Adam Strzelczyk, Susanne Schubert‐Bast
Expert Review of Neurotherapeutics (2020) Vol. 20, Iss. 10, pp. 1065-1079
Open Access | Times Cited: 51
Association Between Treatment Progression, Disease Refractoriness, and Burden of Illness Among Hospitalized Patients With Status Epilepticus
Elan L. Guterman, John P. Betjemann, Alex A. Aimetti, et al.
JAMA Neurology (2021) Vol. 78, Iss. 5, pp. 588-588
Open Access | Times Cited: 49
A multicenter, matched case‐control analysis comparing burden‐of‐illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany
Adam Strzelczyk, Susanne Schubert‐Bast, Thomas Bast, et al.
Epilepsia (2019) Vol. 60, Iss. 8, pp. 1697-1710
Open Access | Times Cited: 48
Treatment of refractory and superrefractory status epilepticus with topiramate: A cohort study of 106 patients and a review of the literature
Anne Fechner, Kristina Hubert, Kolja Jahnke, et al.
Epilepsia (2019) Vol. 60, Iss. 12, pp. 2448-2458
Open Access | Times Cited: 44
Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort)
Claudine Sculier, Cristina Barcia Aguilar, Nicolas Gaspard, et al.
Epilepsia (2021) Vol. 62, Iss. 7, pp. 1629-1642
Open Access | Times Cited: 38
Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany
Adam Strzelczyk, Milka Pringsheim, Patrick May, et al.
Epilepsia (2021) Vol. 62, Iss. 10, pp. 2518-2527
Open Access | Times Cited: 33
Mortality, Disability, and Prognostic Factors of Status Epilepticus
Sun Ah Choi, Hyesung Lee, Kyuwoong Kim, et al.
Neurology (2022) Vol. 99, Iss. 13
Closed Access | Times Cited: 24
Refractory Status Epilepticus
Isabelle Beuchat, Felix Rosenow, Christoph Kellinghaus, et al.
Neurology (2022) Vol. 99, Iss. 16
Closed Access | Times Cited: 23
Epidemiology, real-world treatment and mortality of patients with status epilepticus in Germany: insights from a large healthcare database
Antje Mevius, Lars Joeres, P Gille, et al.
Brain Communications (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 15
Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Disorders of Speech and Language: Evaluation of German Health Insurance Data
Martin Sommer, Andrea Waltersbacher, Andreas Schlotmann, et al.
Frontiers in Human Neuroscience (2021) Vol. 15
Open Access | Times Cited: 29
Burden of status epilepticus: prognosis and cost driving factors, insight from a nationwide retrospective cohort study of the French health insurance database
Quentin Calonge, François Le Gac, Mario Chávez, et al.
Journal of Neurology (2024) Vol. 271, Iss. 10, pp. 6761-6772
Closed Access | Times Cited: 4
Epidemiology of status epilepticus in the United States: A systematic review
Mei Lü, Mareva Faure, Aurore Bergamasco, et al.
Epilepsy & Behavior (2020) Vol. 112, pp. 107459-107459
Open Access | Times Cited: 31
General Trends in Prices and Prescription Patterns of Anticonvulsants in Germany between 2000 and 2017: Analysis of National and Cohort-Based Data
Laurent M. Willems, Hajo M. Hamer, Susanne Knake, et al.
Applied Health Economics and Health Policy (2019) Vol. 17, Iss. 5, pp. 707-722
Closed Access | Times Cited: 30
Epileptic Status in a PEDiatric cohort (ESPED) requiring intensive care treatment: A multicenter, national, two‐year prospective surveillance study
Sascha Meyer, Jaro Langer, Martin Poryo, et al.
Epilepsia Open (2023) Vol. 8, Iss. 2, pp. 411-424
Open Access | Times Cited: 10
Advancements in Valproate Therapy for Seizures, Migraines and Bipolar Disorders
Laxminarayana Kurady Bairy, Sampath Madhyastha
Medical Principles and Practice (2025), pp. 1-19
Open Access
Treatment of convulsive status epilepticus in Brazil: a review
Luís Otávio Sales Ferreira Caboclo
Arquivos de Neuro-Psiquiatria (2025) Vol. 83, Iss. 01, pp. 001-010
Open Access
A Case Series and Review of Febrile-Infection Related Epilepsy Syndrome (FIRES)
Tahnee Spoden, Alice Hoftman, Nanci Rascoff, et al.
Children (2025) Vol. 12, Iss. 4, pp. 485-485
Open Access
Synaptic inhibitory dynamics drive benzodiazepine response in pediatric status epilepticus
Tommaso Fedele, Richard J. Burman, Anne Steinberg, et al.
Epilepsia (2025)
Open Access
Intranasal midazolam as first‐line inhospital treatment for status epilepticus: a pharmaco‐EEG cohort study
Lara Kay, Nina Merkel, Anemone von Blomberg, et al.
Annals of Clinical and Translational Neurology (2019) Vol. 6, Iss. 12, pp. 2413-2425
Open Access | Times Cited: 29
Recent advances in the pharmacotherapy of epilepsy: brivaracetam and perampanel as broad-spectrum antiseizure drugs for the treatment of epilepsies and status epilepticus
Laurent M. Willems, Sebastian Bauer, Felix Rosenow, et al.
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 14, pp. 1755-1765
Closed Access | Times Cited: 27
Seizure management and prescription patterns of anticonvulsants in Dravet syndrome: A multicenter cohort study from Germany and review of literature
Susanne Schubert‐Bast, Markus Wolff, Adelheid Wiemer‐Kruel, et al.
Epilepsy & Behavior (2019) Vol. 98, pp. 88-95
Open Access | Times Cited: 27
Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring
Anemone von Blomberg, Lara Kay, Susanne Knake, et al.
CNS Drugs (2020) Vol. 34, Iss. 5, pp. 545-553
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top